4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0000950170-24-030250
Options or other derivatives
- Chief Commercial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Von Seggern Christopher · Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-11 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +100,000 | 100,000 | D |
Loading xslF345X05/ownership.xml…